Are there any concerns with taking Wellbutrin (bupropion) while smoking cigarettes?

Wellbutrin and Smoking Cigarettes: Safety Considerations

Taking Wellbutrin (bupropion) while actively smoking cigarettes is generally safe and is actually the intended use when bupropion is prescribed for smoking cessation. The medication is specifically designed to be started 1-2 weeks before the quit date, meaning patients continue smoking during the initial treatment period 1.

Key Safety Points

No Direct Drug-Cigarette Interaction

There is no dangerous pharmacological interaction between bupropion and cigarette smoking itself. In fact, bupropion is FDA-approved specifically to help people quit smoking, with the standard protocol involving continued smoking during the first 1-2 weeks of treatment 2. The medication works by inhibiting dopamine and noradrenaline reuptake, reducing nicotine cravings and withdrawal symptoms 1.

Important Safety Concerns to Monitor

Seizure Risk (Most Critical)

• Bupropion lowers the seizure threshold with approximately 0.1% seizure risk 1
• Absolute contraindications: history of seizures, brain metastases, stroke, severe head injury, eating disorders (anorexia/bulimia), or abrupt alcohol/benzodiazepine withdrawal 1
• Maximum dose: 300 mg/day (150 mg twice daily for SR formulation) 1
• Risk increases with higher doses or when combined with other medications that lower seizure threshold

Neuropsychiatric Effects

• Monitor for depression, suicidal ideation, agitation, hostility, or behavioral changes 1, 2
• The large EAGLES trial (n=8,144) found no significant increase in neuropsychiatric adverse events with bupropion compared to placebo or nicotine patch 1
• However, the FDA requires black box warnings about these potential effects 2
• Symptoms may represent nicotine withdrawal rather than medication effects 2

Common Side Effects

• Insomnia, dry mouth, headaches, and nausea are most frequent 1
• These are generally transient and often resolve without intervention 3
• Side effects are considered "an acceptable risk compared to smoking" 1

Cardiovascular Safety

Recent meta-analyses show no elevated cardiovascular risk with bupropion for smoking cessation 1. This is reassuring for patients with cardiovascular disease, though monitoring blood pressure is recommended as some patients may develop hypertension 2.

Clinical Algorithm for Safe Use

Before Prescribing:

1. Screen for seizure risk factors (history of seizures, brain injury, eating disorders, alcohol use)
2. Screen for current psychiatric conditions requiring monitoring
3. Review all medications for potential interactions (MAO inhibitors, other drugs lowering seizure threshold)
4. Verify patient is not taking tamoxifen or has closed-angle glaucoma 1

During Treatment:

• Start 1-2 weeks before planned quit date while patient continues smoking 1
• Titrate: Days 1-3: 150 mg once daily; Day 4 onward: 150 mg twice daily 1
• Monitor closely for neuropsychiatric symptoms, especially in first few weeks
• If seizure occurs, immediately discontinue and do not restart 2

Common Pitfalls to Avoid

1. Don't withhold bupropion because patient is still smoking - this is the expected scenario during initiation
2. Don't exceed 300 mg/day total dose - seizure risk increases significantly
3. Don't ignore psychiatric history - while EAGLES trial was reassuring, closer monitoring is warranted in patients with mental health conditions
4. Don't forget drug interactions - bupropion is a potent enzyme inhibitor affecting antidepressants, antiarrhythmics, and antipsychotics 4

Bottom Line

The primary concerns with Wellbutrin are seizure risk (requiring careful patient selection) and neuropsychiatric monitoring - not the combination with cigarette smoking itself. The medication is designed to be used while smoking, with efficacy demonstrated across multiple trials showing 1.64 times higher quit rates compared to placebo 5. The benefits of smoking cessation substantially outweigh the minimal and manageable risks of bupropion therapy in appropriately selected patients 1.